1 |
Lacolley P, Regnault V, Nicoletti A, et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles[J].Cardiovasc Res,2012,95(2):194-204.
|
2 |
Qiu J, Zheng Y, Hu J, et al. Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding[J]. J R Soc Interface,2014,11(90):20130852.
|
3 |
王桂清.血液动力学在血管重构中的作用[J].基础医学与临床,2004,24(3): 264-268.
|
4 |
Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review[J]. J Hypertens,2006,24(6):983- 991.
|
5 |
Siow RC, Churchman AT. Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in[J].Cardiovasc Res,2007,75(4):659- 668.
|
6 |
Hansen NU, Willumsen N, Sand JM, et al. Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling[J].Clin Biochem,2016,49(12):903- 908.
|
7 |
郭雪峰,张继东,姜红,等.芩丹胶囊对老年自发性高血压大鼠血管外膜Ⅰ、Ⅲ型胶原表达的影响[J].中国中西医结合杂志,2010,30(11):1178-1182.
|
8 |
Belo VA, Guimarães DA, Castro MM. Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension[J].J Vasc Res,2015,52(4):221-231.
|
9 |
Belo VA, Parente JM, Tanus-Santos JE, et al. Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension[J]. Biochem Pharmacol, 2016,118:50-58.
|
10 |
李征,李茹香,武新民,等.MMP-9与TGF-β-1在高血压血管重构中的作用及阿托伐他汀的干预研究[J].中国药物与临床,2008,8(2):113-115.
|
11 |
Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84(3): 767- 801.
|
12 |
郝日雯,关伟,郭继龙,等.电针对二肾一夹高血压大鼠血压、血管重构的影响研究[J].山西中医学院学报,2017,18(4):16-19.
|
13 |
Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells[J].Circ Res,1993,73(1):193-204.
|
14 |
王博,张继东,冯进波,等.芩丹胶囊对自发性高血压大鼠血管重构以及骨桥蛋白基因表达的影响[J].南京中医药大学学报,2007,23(3):157-160,205.
|
15 |
王爱丽,王雪,朱太卿.醒脑开窍针法联合依达拉奉治疗急性脑出血的疗效观察及对血清OPN、CGRP水平的影响[J].上海针灸杂志,2021,40(8):913- 919.
|
16 |
王立文,刘光耀,胡渝生,等.血管紧张素Ⅱ和转移生长因子β1在二肾一夹高血压大鼠血管重构中的作用[J].中国心血管杂志,2003,8(2):83-84,88.
|
17 |
王紫娟.电针"百会"、"太冲"对SHR主动脉损伤的保护作用及其机制研究[D].北京中医药大学,2019.
|
18 |
Berkban T, Boonprom P, Bunbupha S, et al. Ellagic Acid Prevents L-NAME-Induced Hypertension via Restoration of eNOS and p47phox Expression in Rats[J].Nutrients,2015,7(7):5265-5280.
|
19 |
鄢定红,程晓曙,王雪梅,等.一氧化氮缺乏在高血压及心血管重构中的作用[J].高血压杂志,2000,8(4):77-82,20.
|
20 |
Bouvet C, Gilbert LA, Girardot D, et al. Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition[J].Hypertension,2005,45(3):432- 437.
|
21 |
Rizzi E, Amaral JH, Guimarães DA, et al. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects[J].Free Radic Biol Med,2019,130:234-243.
|
22 |
陈颖哲,刘巍,张天宇,等.针刺泻法对高血压中医证候及血清NO、ET-1水平的影响[J].中西医结合心脑血管病杂志,2021,19(2):217-220.
|
23 |
王家有,唐纯志,贺振泉,等.针刺太冲穴对自发性高血压大鼠收缩压、血浆内皮素-1和血清NO的影响[J].广东医学,2010,31(15):1943-1945.
|
24 |
Goumans MJ, Liu Z, Ten Dijke P. TGF-beta signaling in vascular biology and dysfunction[J].Cell Res,2009,19(1):116-127.
|
25 |
葛汝青,张继东,黄山英,等.芩丹胶囊对高血压血管外膜重构及TGF-β1/Smad信号转导通路的影响[J].山东大学学报(医学版),2011,49(4):7-12.
|
26 |
葛汝青,张继东,黄山英,等.芩丹胶囊对老年自发性高血压大鼠血管外膜重构作用机制的研究[J].上海中医药杂志,2011,45(3):62- 66.
|
27 |
Prado AF, Batista RIM, Tanus-Santos JE, et al. Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations[J].Biomolecules,2021,11(4):585.
|
28 |
Castro MM, Cena J, Cho WJ, et al. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats[J].Arterioscler Thromb Vasc Biol,2012,32(3):662- 668.
|
29 |
Parente JM, Pereira CA, Oliveira-Paula GH, et al. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling[J].Basic Clin Pharmacol Toxicol,2017,121(4):246-256.
|